Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $553.66 USD
Change Today +6.56 / 1.20%
Volume 501.1K
REGN On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert E. Landry Jr.

Chief Financial Officer and Senior Vice President of Finance, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2014


Mr. Robert E. Landry Jr., also known as Bob, Jr. has been Senior Vice President of Finance at Regeneron Pharmaceuticals, Inc since September 2013 and Chief Financial Officer since October 1, 2013. Mr. Landry has responsibility for all financial functions, including Controller's, Treasury, Financial Planning, Tax, and Internal Audit. In his new role, Mr. Goldberg continue to have responsibility for Alliance Management and various administrative functions. He served as ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-847-7000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


University of Notre Dame

Other Affiliations*

Annual Compensation*

Total Annual Compensation$905,000

Stock Options*

All Other Compensation$14,818
Exercisable Options20,000
Exercisable Options Value$2,751,000
Unexercisable Options94,000
Unexercisable Options Value$8,613,060
Total Value of Options$11,364,060
Total Number of Options114,000

Total Compensation*

Total Annual Cash Compensation$919,818
Total Short Term Compensation$905,000
Other Long Term Compensation$14,818
Total Calculated Compensation$7,322,956
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $553.66 USD +6.56


Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Nobuo Hanai Ph.D.Chief Executive Officer, President and Representative Director
Kyowa Hakko Kirin Co., Ltd.
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at